Related Experiment Videos
Gene expression of perforin and granzyme A in the liver in chronic hepatitis C: comparison with peripheral blood
R Fukuda1, N Ishimura, X T Nguyen
1Department of Internal Medicine, Shimane Medical University, Japan.
Insights
Perforin, a key cytotoxic T cell effector, is expressed in the liver of chronic hepatitis C patients but not in their peripheral blood. This suggests perforin
Area of Science:
- Immunology
- Hepatology
- Molecular Biology
Background:
- Cytotoxic T lymphocytes (CTLs) are crucial for cell-mediated immunity, utilizing effector molecules like perforin and granzyme A.
- The role of these CTL effector molecules in chronic viral hepatitis, particularly Hepatitis C, remains largely uncharacterized.
Purpose of the Study:
- To investigate the expression patterns of perforin and granzyme A mRNA in chronic hepatitis C.
- To determine the specific sites of effector molecule expression (liver vs. peripheral blood) in chronic hepatitis C patients.
Main Methods:
- Quantitative analysis of perforin and granzyme A mRNA expression.
- Utilized reverse transcription polymerase chain reaction (RT-PCR).
- Samples included liver biopsy specimens and peripheral mononuclear cells (PBMC) from 21 chronic hepatitis C patients and 5 controls.
Main Results:
- Perforin mRNA was exclusively detected in the liver tissue of chronic hepatitis C patients, absent in control livers.
- Conversely, perforin mRNA was not found in the peripheral mononuclear cells (PBMC) of patients (P < 0.01).
- Granzyme A mRNA was expressed in both liver and PBMC across all subjects, including controls.
Conclusions:
- Perforin plays a significant role as an effector molecule in the lysis of hepatocytes during chronic hepatitis C.
- The localized expression of perforin in the liver highlights its specific involvement in the hepatic immune response to Hepatitis C virus.
Abstract:
Perforin and granzyme A are the major effectors of cytotoxic T cells in cell-mediated cytotoxicity. However, there has been no report on these effectors in chronic viral hepatitis. In the present study, the expression of perforin and granzyme A mRNA was investigated by the reverse transcription polymerase chain reaction method using liver biopsy specimens and peripheral mononuclear cells (PBMC) from 21 patients with chronic hepatitis C and 5 control cases. Perforin mRNA was detected only in the liver of chronic hepatitis patients but not in the control livers. Conversely, perforin mRNA was not expressed in PBMC of the patients with chronic hepatitis (P < 0.01). Granzyme A mRNA was detected both in the liver and PBMC of all the cases including control cases. These results indicated that the perforin is an important effector molecule in the hepatocyte lysis in chronic viral hepatitis C.